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Summary
Bordetella species cause respiratory infections in
mammals. Their master regulatory system BvgAS con-
trols expression of at least three distinct phenotypic
phases in response to environmental cues. The Bvg+
phase is necessary and sufficient for respiratory infec-
tion while the Bvg− phase is required for survival
ex vivo. We obtained large colony variants (LCVs)
from the lungs of mice infected with B. bronchiseptica
strain RBX9, which contains an in-frame deletion
mutation in fhaB, encoding filamentous haemaggluti-
nin. RBX9 also yielded LCVs when switched from Bvg−
phase conditions to Bvg+ phase conditions in vitro. We
determined that LCVs are composed of both Bvg+ and
Bvg− phase bacteria and that they result from defective
bvgAS positive autoregulation. The LCV phenotype
was linked to the presence of a divergent promoter
5′ to bvgAS, suggesting a previously undescribed
mechanism of transcriptional interference that, in this
case, leads to feedback-based bistability (FBM). Our
results also indicate that a small proportion of RBX9
bacteria modulates to the Bvg− phase in vivo. In addi-
tion to providing insight into transcriptional interfer-
ence and FBM, our data provide an example of an
in-frame deletion mutation exerting a ‘polar’ effect on
nearby genes.
Introduction
The genus Bordetella includes Gram-negative bacteria
that cause respiratory infections. Bordetella pertussis
and Bordetella parapertussishu are strictly human-specific
pathogens that cause whooping cough, an acute disease
that has experienced a recent resurgence despite wide-
spread vaccination (Campos-Outcalt, 2005; Mattoo and
Cherry, 2005; Marconi et al., 2012). Phylogenetic analyses
indicate that B. pertussis and B. parapertussishu have
recently evolved from Bordetella bronchiseptica, which
infects a wide range of mammals and can also survive
naturally for long periods of time outside the host (Gerlach
et al., 2001; Diavatopoulos et al., 2005; Gross et al.,
2010). Although the factors that determine host specificity
remain unknown, the presence and regulation of virulence
factor-encoding genes is highly conserved between these
three subspecies (Tejada et al., 1996; Cummings et al.,
2006).
Filamentous haemagglutinin (FHA), encoded by the
fhaB gene, is a well-characterized virulence factor of Bor-
detella and is a primary component of acellular pertussis
vaccines (Domenighini et al., 1990; Sato and Sato, 1999;
Mattoo and Cherry, 2005). A prototypical member of the
Two Partner Secretion family of proteins, FHA is a large,
surface-exposed protein that is produced and secreted at a
high levels during growth in vitro (Domenighini et al., 1990;
Coutte et al., 2001; Mazar and Cotter, 2006). In B. bron-
chiseptica, FHAmediates adherence to a wide range of cell
lines and is required for colonization of the lower respira-
tory tract in both rats and mice (Cotter et al., 1998; Mattoo
et al., 2000; Inatsuka et al., 2005). Although FHA was first
characterized as an adhesin, it has subsequently been
reported to perform several other important functions.
For example, exposure of lipopolysaccharide and IFN-γ-
stimulated macrophages to purified B. pertussis FHA
suppresses interleukin-12 (IL-12) production, and macro-
phages treated with FHA exhibit higher rates of apoptosis
compared with untreated controls (McGuirk and Mills,
2000; Abramson et al., 2001). FHA-deficient B. bron-
chiseptica causes an infection that is hyperinflammatory
compared with infection caused by wild-type bacteria and
is characterized by increased influx of interleukin-17 (IL-
17)-positive neutrophils, macrophages, and CD4+ T cells,
suggesting that FHA plays an immunomodulatory role in
vivo (Inatsuka et al., 2005; Henderson et al., 2012). Addi-
tionally, there is strong evidence that FHA interacts with
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another important virulence factor, adenylate cyclase toxin
ACT (Zaretzky et al., 2002; Perez Vidakovics et al., 2006).
In Bordetella, the master regulator that controls the
expression of all known virulence factor-encoding genes
is called BvgAS (Aricò et al., 1989). A two-component
sensory transduction system, BvgAS controls at least
three distinct phenotypic phases (Bvg+, Bvgi, and Bvg−) by
altering gene expression patterns in response to environ-
mental stimuli (Fig. 1A) (Cotter and Jones, 2003). The Bvg+
phase is induced during standard laboratory growth con-
ditions at 37°C on Bordet–Gengou (BG) blood agar or in
Stainer–Scholte (SS) broth. Bvg+ phase bacteria are non-
motile and form small, dome-shaped, haemolytic colonies
on BG blood agar. Bacteria can be induced (or modulated)
to the Bvg− phase in the laboratory by growth at room
temperature or by supplementing media with millimolar
concentrations of chemical modulators such as MgSO4
or nicotinic acid. Bacteria in the Bvg− phase are motile
(B. bronchiseptica only) and form large, flat, non-
haemolytic colonies. The Bvgi phase can be induced in the
laboratory with intermediate concentrations of chemical
modulators and these bacteria form colonies that appear
phenotypically intermediate compared with Bvg− and Bvg+
phase colonies. Each phenotypic phase is defined by a
unique pattern of gene expression (Fig. 1B) (Cotter and
Miller, 1997; Cotter and Jones, 2003; Cummings et al.,
2006). For example, bacteria in the Bvg+ phase are char-
acterized by maximal expression of virulence-activated
genes (vags) such as fhaB, cyaA-E (encoding adenylate
cyclase toxin ACT), ptxA-E (encoding pertussis toxin in
B. pertussis), and bvgAS itself (which is positively
autoregulated). In contrast, Bvg− phase bacteria maximally
express virulence-repressed genes (vrgs) including those
required for motility (i.e. flaA, encoding flagellin and frlAB,
the Bordetella flhDC homologue) and chemotaxis (B. bron-
chiseptica only) but do not express vags. The vags fall
into two classes: those expressed in the Bvgi phase and
the Bvg+ phase, and those expressed maximally only
in the Bvg+ phase. Additionally, some genes, such as
bipA (encoding Bvg-intermediate phase protein A), are
expressed maximally only in the Bvgi phase (Deora et al.,
2001; Williams et al., 2005). Thus, Bvgi phase bacteria are
characterized by maximal expression of bipA, bvgAS, and
fhaB, and minimal expression of vrgs, cyaA, and ptxA
(B. pertussis only) (Fig. 1B) (Cotter and Miller, 1997; Deora
et al., 2001; Stockbauer et al., 2001; Williams et al., 2005;
Cummings et al., 2006).
Upon activation of the BvgAS phosphorelay in response
to environmental signals, BvgS (the sensor kinase)
autophosphorylates, becoming the substrate for BvgA
(the response regulator). BvgA-phosphate (BvgA∼P) binds
DNA and activates or represses transcription (Boucher
et al., 2001a,b; 2003; Cotter and Jones, 2003; Jones et al.,
2005; Williams et al., 2005). In vitro transcription and DNA
binding experiments have identified both high and low
affinity BvgA binding sites located at various positions
relative to the transcription start sites of BvgAS-regulated
genes (Steffen et al., 1996; Boucher et al., 2001b; Cotter
and Jones, 2003; Jones et al., 2005; Williams et al., 2005).
These data, together with a recent report describing a
direct assessment of BvgA∼P levels in B. pertussis cul-
tures (Boulanger et al., 2013), support a model in which
BvgA∼P levels are extremely low under Bvg− phase condi-
tions, moderate under Bvgi phase conditions, and high
under Bvg+ phase conditions (Cotter and Jones, 2003;
Boulanger et al., 2013). In addition to controlling distinct
phenotypic phases in response to steady-state conditions,
BvgAS can regulate gene expression in a temporal manner
(Scarlato and Rappuoli, 1991; Prugnola et al., 1995; Jones
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Fig. 1. The Bordetella BvgAS system controls at least four
different classes of genes and three different phenotypic phases in
response to environmental stimuli.
A. BvgAS is responsible for the Bvg+, Bvgi, and Bvg− phases and is
repressed by chemical modulators or low temperature.
B. The three phenotypic phases are defined by unique patterns of
gene expression as indicated, and rely on the intracellular
concentration of BvgA∼P.
C. The chromosomal organization of the fhaB and bvgAS loci in
RB50 (top) and RBX9 (ΔfhaB, bottom). Red regions indicate
relative BvgA binding regions.
Phenotypic bistability in Bordetella 717
© 2013 John Wiley & Sons Ltd, Molecular Microbiology, 90, 716–733
et al., 2005; Williams and Cotter, 2007). Because bvgAS is
positively autoregulated, both the concentration of BvgA
and the proportion that is phosphorylated increase when
bacteria sense activating signals. Therefore, gene expres-
sion patterns change temporally as the total concentration
of BvgA∼P gradually increases when bacteria are switched
from Bvg− to Bvg+ phase conditions (Scarlato and
Rappuoli, 1991; Prugnola et al., 1995; Jones et al., 2005;
Williams and Cotter, 2007).
The bvgAS and fhaB genes are adjacent and transcribed
divergently. Experiments with B. pertussis indicate that the
426 bp intergenic region contains at least three promoters
(with at least two that control bvgAS, called P2 and P1) and
multiple high-affinity BvgA binding sites (Scarlato et al.,
1990; Roy and Falkow, 1991; Boucher et al., 2001a,b)
(Fig. 1C). In the Bvg− phase, bvgAS transcription is driven
by the BvgAS-independent promoter P2 that is responsible
for basal levels of BvgA (which likely remain unphosphor-
ylated) (Scarlato et al., 1990; Roy and Falkow, 1991).
When switched to the Bvg+ phase, BvgA becomes phos-
phorylated and activates fhaB and bvgAS via binding to
high-affinity sites near PfhaB and P1 (Roy and Falkow, 1991;
Zu et al., 1996). Once a relatively high concentration
of BvgA∼P is achieved, genes with low-affinity BvgA
binding sites at their promoters, such as cyaA and ptxA in
B. pertussis, are activated and the bacteria transition into
the Bvg+ phase (Karimova et al., 1996; Jones et al., 2005;
Williams and Cotter, 2007). The Bvg+ phase, and therefore
high levels of BvgA∼P, is maintained as long as bacteria
sense a Bvg+ phase environment. Without bvgAS positive
autoregulation, the ability of B. bronchiseptica to transition
between and maintain each phenotypic phase is compro-
mised (Williams and Cotter, 2007).
Data obtained thus far indicate that the Bvg+ phase is
necessary and sufficient to cause respiratory infection, the
Bvg− phase facilitates survival outside of the host, and
BvgAS modulation to the Bvgi or Bvg− phase does not
occur during infection (Cotter and Miller, 1994; Akerley
et al., 1995; Merkel et al., 1998; Tejada et al., 1998;
Vergara-Irigaray et al., 2005; Nicholson et al., 2012). For
example, several groups have shown that Bvg+ phase-
locked bacteria behave identically to wild-type bacteria
in colonization, persistence, and contribution to lung
pathology (Cotter and Miller, 1994; Akerley et al., 1995;
Tejada et al., 1998; Nicholson et al., 2012). In contrast,
Bvg− phase-locked bacteria cannot establish an infection
and Bvgi phase-locked bacteria are severely limited in
colonization and persistence (Cotter and Miller, 1994;
1997; Tejada et al., 1998; Vergara-Irigaray et al., 2005;
Nicholson et al., 2012). Additionally, we recently demon-
strated that flaA is not expressed at a detectable level when
mice are infected with the B. bronchiseptica wild-type
strain RB50 (Byrd et al., 2013) and Akerley et al. showed
that production of flagella in the Bvg+ phase is detrimental
to infection (Akerley et al., 1995). Although the natural
signals that affect BvgAS activity and the role of modulation
in nature remain unknown, all of these data suggest that
wild-type Bordetella do not modulate to the Bvg− phase
within the mammalian host.
Bordetella bronchiseptica strain RBX9, which contains
an in-frame deletion mutation of fhaB (Fig. 1C), has been
used extensively to characterize the function of FHA in vitro
and in vivo (Cotter et al., 1998; Irie et al., 2004; Inatsuka
et al., 2005; Mazar and Cotter, 2006; Julio et al., 2009;
Henderson et al., 2012). RBX9 is defective in adherence to
multiple cell lines, is unable to autoaggregate in liquid
culture, and causes hyperinflammation in the murine lung
infection model (Cotter et al., 1998; Mattoo et al., 2000;
Inatsuka et al., 2005; Julio et al., 2009; Henderson et al.,
2012). We isolated large colony variants (LCVs) from mice
infected with RBX9 and also by modulating RBX9 to the
Bvg− phase in vitro. We determined that the LCVs were a
product of transcriptional interference that influenced
bvgAS and produced an unusual bistable phenotype.
Despite evidence suggesting that Bordetella do not modu-
late during infection, the discovery of LCVs indicates that a
subpopulation of RBX9 bacteria modulates in vivo.
Results
Isolation and characterization of LCVs
While comparing wild-type B. bronchiseptica strain RB50
with its ΔfhaB derivative RBX9 in a murine lung infection
model, we noticed that at early time points post-
inoculation (12 and 24 h), a small proportion (∼ 1%) of
colony-forming units (cfu) recovered from the lungs of
RBX9-inoculated mice formed colonies on BG blood agar
(Bvg+ phase conditions) that were larger, flatter, and less
haemolytic than colonies typically formed by RBX9 and
RB50 (Table 1) (Fig. 2D). These LCVs were not recovered
from RB50-infected mice. When LCVs were picked,
diluted, and replated on BG blood agar, approximately
95% of the resulting colonies were phenotypically Bvg+
phase, and approximately 5% were LCVs (Table 1)
Table 1. LCV recovery frequency.
Condition
%a LCVs
recovered
on BG
blood agar
Plating murine lung homogenate after 30 h 0.39 ± 0.13
Replating any RBX9 Bvg− phase colony 5.43 ± 0.98
Replating an LCV from BG agar (derived in vitro) 3.90 ± 0.80
Replating an LCV from BG agar (derived in vivo) 6.03 ± 1.26
Replating any RBX9 Bvg+ phase colony 0
a. Values are means ± standard errors for experiments performed at
least in triplicate.
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(Fig. 2H). When replated again, LCVs continued to yield
95% Bvg+ phase colonies and 5% LCVs. All phenotypi-
cally Bvg+ phase colonies yielded only phenotypically
Bvg+ phase colonies after replating onto BG agar.
We found serendipitously that LCVs were also induced
in vitro under certain conditions. Specifically, when RBX9
was grown on BG blood agar + 50 mM MgSO4 (Bvg−
phase conditions) and then replated onto BG blood agar –
effectively switching the bacteria from Bvg− to Bvg+ phase
conditions – approximately 95% of the colonies were
phenotypically Bvg+ phase and 5% were LCVs (Table 1)
(Fig. 2C). When these LCVs were picked, diluted, and
replated onto BG blood agar, approximately 95% of colo-
nies displayed the Bvg+ phase morphology and approxi-
mately 5% of colonies were LCVs (Table 1) (Fig. 2G).
Again, all phenotypically Bvg+ phase colonies yielded only
phenotypically Bvg+ phase colonies after replating onto
BG agar. When RBX9 was streaked onto BG agar sup-
plemented with 50 mM MgSO4, or passaged continuously
under Bvg− phase conditions, all colonies displayed
typical Bvg− phase morphology.
To determine if the generation of LCVs in RBX9 was
due to the ΔfhaB mutation and not an unknown second-
ary mutation, we reconstructed strain RBX9 by allelic
exchange. The newly constructed strain behaved identi-
cally to RBX9, producing LCVs following BvgAS modu-
lation and generating a similar proportion of LCVs upon
restreaking an LCV onto BG blood agar. Although LCVs
appear morphologically similar to Bvgi phase colonies
(Fig. 2), the fact that restreaking LCVs yielded a hetero-
geneous population of morphologically different colonies
indicates that the ΔfhaB mutation does not lock bacteria
into one particular phenotypic phase (such as the Bvgi
phase).
LCVs are composed of both Bvg− and Bvg+
phase bacteria
To better understand the properties of LCVs, we investi-
gated specific gene expression patterns within the bacteria
that composed them. The fact that LCVs are haemolytic
suggests that cyaA, a Bvg+ phase gene, is expressed
because ACT is responsible for haemolysis on BG blood
agar (Bellalou et al., 1990). Additionally, electron micro-
graphs of negatively stained LCVs revealed the presence
of numerous flagella, which are only produced in the Bvg−
phase (data not shown). To determine if bacteria within
LCVs were motile, we grew bacteria on SS plates with
0.3% agar (Bvg+ phase conditions). LCVs stab-inoculated
into this agar produced a zone of migration that was
smaller than that produced by Bvg− phase-locked bacteria,
but larger than Bvg+ and Bvgi phase bacteria, which do not
produce a zone of migration (data not shown), suggesting
that at least some bacteria within LCVs are motile.
Together, our observations indicate that both cyaA and flaA
are expressed within each LCV. However, previous studies
have shown that expression of vags, such as cya, and
vrgs, such as flaA, is mutually exclusive (Cummings et al.,
2006). Therefore, we hypothesized that LCVs are com-
posed of at least two phenotypically distinct populations of
bacteria: a population in the Bvg+ phase and a population in
the Bvg− phase.
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48 h. (A) RB50; (B) RBX9; (C) RBX9 LCV produced after in vitro modulation: (D) RBX9 LCV recovered from mouse lung homogenate; (E)
RB50i (a Bvg-intermediate phase-locked strain in the RB50 background); (F) RBX9i (a Bvg-intermediate phase-locked strain in the RBX9
background); (G) RBX9 restreak of an LCV produced after modulation; (H) RBX9 restreak of an LCV recovered from the mouse lung; (I)
RB50; (J) RBX9; (K) RBX9 restreak of an LCV produced after modulation; (L) RBX9 restreak of an LCV recovered from the mouse lung.
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To determine the phenotypes of individual bacteria
present in each LCV, we created RBX9BatB-HAfla-gfp,
a strain that contains two unique tags that permit the
distinction between Bvg+ and Bvg− phase bacteria.
RBX9BatB-HAflaA-gfp contains an HA epitope-encoding
sequence in batB (encoding the Bvg+ phase surface-
exposed protein BatB) as well as gfp driven by the flaA
promoter at a neutral site in the chromosome. The batB
gene is expressed maximally in the Bvg+ phase and mini-
mally in the Bvgi and Bvg− phases (Williams et al., 2008).
The flaA gene, as described previously, is a typical vrg
and contains a strong promoter that is active only in the
Bvg− phase (Akerley et al., 1992; Cotter and Jones,
2003). Therefore, Bvg+ phase bacteria should produce a
surface-exposed HA-tagged BatB protein and be GFP−
and Bvg− phase bacteria should be GFP+ and lack a
surface-exposed HA epitope.
We used Alexa-Fluor 594-conjugated antibodies to indi-
rectly recognize HA epitopes so that BatB-producing bac-
teria displayed red fluorescence. Bacteria expressing fla-
gfp produced GFP and displayed green fluorescence.
When Bvg+ phase colonies of RBX9BatB-HAfla-gfp were
stained with anti-HA and an Alexa-Fluor 594-conjugated
secondary antibody, only red-fluorescing bacteria were
observed and no green fluorescence was detected
(Fig. 3). When Bvg− phase colonies were stained, only
green-fluorescing bacteria were observed and no red fluo-
rescence was detected. When Bvgi phase colonies were
stained, a small proportion of cells displayed red or green
fluorescence, but the majority of cells were not fluorescent
and no bacteria displayed both red and green fluores-
cence (Fig. 3). In contrast, when LCVs from RBX9BatB-
HAfla-gfp were stained, approximately half of the bacteria
fluoresced red and approximately half fluoresced green
(Fig. 3). No colocalization of red and green fluorescence
from either LCVs or Bvgi phase colonies was observed,
confirming that the expression of vags and vrgs is mutu-
ally exclusive under these conditions. These data demon-
strate that LCVs are composed of both Bvg+ and Bvg−
phase bacteria and are not a homogeneous population of
Bvgi phase bacteria.
The ΔfhaB mutation in RBX9, but not lack of FHA
protein, is responsible for the LCV phenotype
To determine if the generation of LCVs was due to lack of
FHA protein production or the specific genetic architecture
created by the ΔfhaB mutation in RBX9, we first deter-
mined if other fhaB mutants yielded LCVs. Strain
RB50ΔPfhaB contains a deletion mutation of the fhaB pro-
moter, strain RB50ΔSPfhaB contains a deletion mutation in
fhaB such that the extended signal peptide of FHA is
missing, and strain RB50ΔβhelixfhaB contains a large dele-
tion mutation in the region of fhaB encoding the β-helix
structure (Fig. S1). These strains were analysed for FHA
production by Western blot, and either produced no FHA
protein (RB50ΔPfhaB and RB50ΔSPfhaB) or a severely trun-
cated FHA protein (RB50Δβ-helix) (data not shown). We
grew these strains under Bvg− phase conditions and plated
single colonies onto Bvg+ phase conditions to determine if
they would produce LCVs similar to RBX9. No LCVs were
observed, suggesting that a lack of wild-type FHAprotein is
not sufficient to produce the LCV phenotype.
To investigate the contribution of the genetic architec-
ture created by the fhaB deletion to the LCV phenotype,
we created RB50::pBam, a strain that produces FHA
and contains an altered fhaB-bvgAS locus (Fig. S1).
RB50::pBam was created by integrating pBam, a suicide
plasmid containing the fhaB-bvgAS intergenic region, into
the RB50 chromosome. When integrated in the chromo-
some, the genetic architecture 5′ to bvgAS is similar in that
fhaB coding sequences are replaced with non-native
sequences (those from the suicide plasmid, in this case).
By contrast with RBX9, however, the complete, intact
fhaB gene, including its promoter region, is present
in RB50::pBam – it is located 5′ (relative to bvgAS) to
the integrated plasmid sequences. After modulation,
RB50::pBam produced LCVs similar to RBX9. These data
suggest that the LCV phenotype can be produced by
altering the genetic architecture 5′ to the fhaB-bvgAS
intergenic region and is independent of FHA production.
The LCV phenotype results from a defect in bvgAS
positive autoregulation
In addition to activating all of the known virulence factor-
encoding genes in Bordetella, BvgAS activates bvgAS
expression through positive autoregulation. Williams et al.
demonstrated that positive autoregulation is required for
the precise transition between and maintenance of the
Bvg+, Bvgi, and Bvg− phases (Williams and Cotter, 2007).
Three observations suggested that LCVs resulted from
defective bvgAS autoregulation in RBX9. First, the muta-
tions that cause LCVs are genetically linked (immediately
5′) to bvgAS; second, LCVs consist of bacteria in least two
separate BvgAS-controlled phenotypic phases; and third,
LCVs were induced in vitro following a switch from Bvg− to
Bvg+ phase growth conditions.
We hypothesized that when RBX9 (or RB50::pBam)
bacteria are switched from Bvg− phase conditions to Bvg+
phase conditions, most, like all wild-type bacteria, are
able to activate transcription at the bvgAS P1 promoter,
leading to increased BvgAS levels and resulting in the
transition to and maintenance of the Bvg+ phase. Accord-
ing to our hypothesis, however, a small subset of RBX9
and RB50::pBam bacteria are unable to activate bvgAS
transcription, possibly due to insufficient levels of BvgA
and/or BvgS, and these bacteria are therefore ‘trapped’ in
720 E. Mason et al. ■
© 2013 John Wiley & Sons Ltd, Molecular Microbiology, 90, 716–733
the Bvg− phase. We hypothesized further that although
some descendants of these ‘Bvg− phase-trapped’ bacteria
will be able to activate bvgAS transcription and hence
‘escape’ to the Bvg+ phase, many will remain Bvg− phase-
trapped and thus a substantial Bvg− phase population will
be maintained in the LCV. An alternate hypothesis is that
LCVs arise from spontaneous or transient shifting of bac-
teria between the Bvg+ and Bvg− phases, which would
also result in a mixture of Bvg+ and Bvg− phase bacteria
within a single colony.
To determine if LCVs contain Bvg− phase-trapped bac-
teria, we used the recombinase-based reporter system
pGFLIP, which creates a permanent genetic change in
response to gene activation (Byrd et al., 2013). In this
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Fig. 3. Detection of Bvg+ (α-HA, red) and Bvg− phase (flaA-gfp, green) bacteria in typical RBX9 colonies and LCVs. RBX9BatBN-HAflaA-gfp
was grown on BG blood agar (Bvg+ phase conditions), BG blood agar + 50 mM MgSO4 (Bvg− phase conditions), or BG blood agar + 6 mM
MgSO4 (Bvgi phase conditions). Several colonies of each phenotype were combined and stained with mouse monoclonal α-HA IgG followed
by an Alexa Fluor 594-conjugated goat anti-mouse IgG secondary antibody. Fluorescence was detected using a Zeiss LSM 710 confocal
microscope.
Phenotypic bistability in Bordetella 721
© 2013 John Wiley & Sons Ltd, Molecular Microbiology, 90, 716–733
system, a promoter of interest drives expression of the
site-specific recombinase-encoding gene flp, which when
activated, results in recombination between Flp recombi-
nase target (FRT) sites that flank gfp and the kanamycin
(Km) resistance gene nptII. Therefore, any activation
(even transient, low-level expression) of flp results in a
permanent loss of Km resistance and GFP fluorescence.
This system targets the reporter construct to the neutral
attTn7 site 3′ to glmS. We created strain RBX9cyaAFLP
by mating the plasmid pGFLIP-PcyaA, in which the B. bron-
chiseptica cyaA promoter drives flp expression, into
RBX9. The cyaA gene is exclusively controlled by BvgAS,
is highly expressed in the Bvg+ phase, and is expressed
minimally in the Bvg− phase (Cotter and Jones, 2003). In
RBX9cyaAFLP, bacteria that have never expressed cyaA
should remain GFP+ and Kmr, whereas bacteria that have
expressed cyaA should convert to GFP− and Kms. If gfp is
lost due to PcyaA activation, all descendent cells will also be
GFP− and Kms.
Previously, we demonstrated that RB50cyaAFLP bac-
teria remain GFP+ under Bvg− phase conditions with Km
selection and that they reach 100% resolution (GFP− cfu/
total cfu) when grown under Bvg+ phase conditions (Byrd
et al., 2013). When RBX9cyaAFLP was plated under Bvg−
phase conditions with Km selection, each colony was
morphologically identical and fluorescent, indicating that
cyaA had not been activated to a level required for suffi-
cient flp expression to lead to recombination between
FRT sites (Fig. 4A). In contrast, when a colony of
RBX9cyaAFLP that was grown under Bvg− phase condi-
tions was plated and grown under Bvg+ phase conditions,
approximately 15% of the colonies were LCVs and
approximately 80% of those LCVs were GFP+ (Fig. 4B).
None of the Bvg+ phase colonies were GFP+. When a
GFP+ LCV was replated and grown under Bvg+ phase
conditions, approximately 5% of the colonies were LCVs
and approximately 80% of those were GFP+ (Fig. 4C). We
serially replated GFP+ LCVs eight times and in all cases,
additional GFP+ LCVs were generated (data not shown).
These data indicate that a significant proportion of bacte-
ria within a GFP+ LCV had never activated cyaA and had
therefore failed to switch to Bvg+ phase in response to a
change in conditions; i.e. they were Bvg− phase-trapped.
Moreover, our data suggest that all LCVs arise from a
Bvg− phase-trapped bacterium and that upon subsequent
multiplication, most descendants have ‘escaped’ to the
Bvg+ phase but a small proportion remain trapped in the
Bvg− phase. These data do not support a model in which
LCVs consist of bacteria that transiently fluctuate between
Bvg+ and Bvg− phase, because if this was true, LCVs
would not be GFP+.
Approximately 20% of the LCV colonies were GFP−,
indicating that PcyaA-flp expression was sufficient to
mediate recombination in the bacterium that founded the
LCV or in its early descendants. Although this result
appears inconsistent with our model, we have observed
previously that when RB50cyaAFLP is grown under Bvg−
phase conditions (when cyaA expression is minimal) and
without Km selection, PcyaA-flp is expressed sufficiently in
approximately 15% of bacteria such that they convert to
GFP− and KmS (Byrd et al., 2013). These data indicate
that the cyaA promoter activity under Bvg− phase condi-
tions is near the threshold level required for flp expression
and subsequent recombination. Therefore, GFP− LCVs
are most likely due to the activity level of the cyaA pro-
moter under Bvg− phase conditions and not due to bacte-
ria switching to the Bvg+ phase and then back to the Bvg−
phase. Nonetheless, our data indicate that in approxi-
mately 80% of LCVs, there are a substantial number of
white GFP
RBX9 cyaAFLP 
A
B
C
Fig. 4. LCVs from the strain RBX9PcyaAFLP are GFP+, indicating
that cyaA has not been activated in a substantial proportion of
these colonies. (A) RBX9PcyaAFLP on BG blood agar + 50 mM
MgSO4 (Bvg− phase conditions); (B) a GFP+ colony from A plated
onto BG blood agar (Bvg+ phase conditions); (C) a GFP+ LCV from
B plated onto BG blood agar (Bvg+ phase conditions). Colonies
were visualized after 48 h of growth.
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bacteria that appear to have a defect in bvgAS positive
autoregulation, leading to the observed Bvg− phase-
trapped population.
Sequences upstream of the fhaB-bvgAS intergenic
region affect the efficiency of bvgAS activation in the
Bvg− phase
Our data indicate that bvgAS autoregulation is defective in
RBX9 and specifically, which LCVs are composed of a
subpopulation of Bvg− phase-trapped bacteria.As stated in
the introduction, bvgAS expression is controlled primarily
by two promoters. Studies with B. pertussis have shown
that under Bvg− phase conditions, P2 is transcribed at a low
basal level (Scarlato et al., 1990; Roy and Falkow, 1991).
This level of transcription results in BvgS levels that
are sufficient to respond to Bvg+ phase conditions by
autophosphorylating and mediating phosphorylation of
BvgA. The resulting BvgA∼P levels are sufficient to bind at
the bvgAS P1 promoter, recruit RNAP, and activate tran-
scription (Zu et al., 1996). (Although similar transcriptional
analyses have not been conducted with B. bronchiseptica,
the nucleotide sequence of the fhaB-bvgAS intergenic
region in B. bronchiseptica is 91.1% identical and most of
those differences are located in regions that, based on
B. pertussis studies, are not bound by either BvgAS or
RNAP.) We considered two hypotheses: (1) the level of
transcription from P2 in RBX9 is lower than in RB50 such
that in some bacteria the levels of BvgAS are too low to
activate transcription at P1 in response to Bvg+ phase
conditions, and (2) transcription activation at P1 by BvgA∼P
is somehow defective in RBX9 compared with RB50. Our
data suggest that defective autoregulation in RBX9 is due
to the lack of native sequences or presence of non-native
sequences 5′ to the fhaB-bvgAS intergenic region.
To test our hypotheses, we constructed
RB50PshortbvgAFLP and RB50PlongbvgAFLP, where
RB50PshortbvgAFLP contains only the fhaB-bvgAS inter-
genic region driving flp and RB50PlongbvgAFLP contains
this region plus an additional 1200 bp of fhaB sequences
driving flp (Fig. 5A). These strains were constructed under
Bvg− phase conditions in the presence of Km. To investi-
gate P2 expression, we determined the percent resolution
(the percentage of cfu that had activated flp) of each strain
grown under Bvg− phase conditions by counting the ratio of
GFP− cfu to total cfu when one colony was plated from Bvg−
phase conditions with Km selection to Bvg− phase condi-
tions without Km selection. The average resolution under
Bvg− phase conditions in RB50PshortbvgAFLP was 68%
whereas the average resolution in RB50PlongbvgAFLP was
97%. Plates are shown from one representative experi-
ment (Fig. 5B and C). Our data indicate that the per-cell
activation of RB50PshortbvgAFLP is lower than the per-cell
activation of RB50PlongbvgAFLP under Bvg− phase condi-
tions, and demonstrate that either a lack of native fhaB
sequences or the presence of non-native sequences has a
direct effect on the efficiency of bvgAS transcription from
the P2 promoter in the Bvg− phase.
When a colony from each strain was grown on Bvg−
phase conditions with Km selection and then plated onto
Bvg+ phase conditions without Km selection, maximum
resolution was achieved and there were no GFP+ colonies
in either strain (Fig. 5D and E). These data suggest that
RBX9 does not have a defect in transcription activation at
P1.
The LCV phenotype is caused by a (divergent)
promoter in proximity to bvgAS
Based on our results, we hypothesized that sequences
within fhaB (1–1200 nucleotides of the coding region) 5′ to
the fhaB-bvgAS intergenic region effect the low level of
transcription from P2 that occurs under Bvg− phase con-
ditions. To test this hypothesis, we constructed a strain
containing a deletion mutation from nt 8 to 1256 of fhaB
(Fig. S1C). This mutant did not produce LCVs when
switched from the Bvg− to the Bvg+ phase. We conclude
that the lack of specific sequences within the first 1200 bp
of fhaB does not cause the LCV phenotype.
These data led us to closely reexamine the genetic
architecture of each strain that produced LCVs (RBX9 and
RB50::pBam) as well as the strains that showed a differ-
ence in bvgAS-flp reporter activation (RB50PshortbvgAFLP
and RB50PlongbvgAFLP). A comparison of these strains
revealed the presence of a divergent promoter 5′ to the
fhaB-bvgAS intergenic region in RBX9, RB50::pBam, and
RB50PshortbvgAFLP (Fig. 6). In RBX9, the fimA promoter is
very close to the fhaB-bvgAS intergenic region, in contrast
to RB50 in which it is separated by the entire (>12 kb) fhaB
gene. In RB50::pBam, the bla promoter (driving expression
of the ampicillin resistance gene on the plasmid) is adja-
cent to the fhaB-bvgAS intergenic region. In the strain
RB50PbvgAshortFLP, the npt promoter (driving expression
of the kanamycin resistance gene on the plasmid) is proxi-
mal to PbvgA-flp, whereas the RB50PbvgAlongFLP reporter is
‘buffered’ from the same npt promoter by an additional
1200 bp of fhaB (Fig. 6). We hypothesized that the pres-
ence of a promoter 5′ to the bvgAS-fhaB intergenic region
was interfering with bvgAS P2 transcription, possibly by
sequestering RNA polymerase away from P2. To test the
hypothesis that a nearby promoter could affect P2 tran-
scription, we reversed the orientation of the insert in the
plasmid pBam. In the resulting plasmid, pBamR, the bla
promoter is no longer proximal to the bvgAS homology
region. Instead, the closest promoter 5′ to bvgAS on the
plasmid is the aaC1 promoter (driving expression of the
gentamicin resistance gene), which is more than 1.5 kb
away (Fig. 6). We created RB50::pBamR by integrating the
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pBamR plasmid into the RB50 chromosome. Modulating
RB50::pBamR and plating bacteria onto Bvg+ phase con-
ditions resulted in all colonies having the typical Bvg+
phase morphology, and no LCVs were observed. The LCV
phenotype was therefore abolished by changing the
sequences upstream of the bvgAS-fhaB region, presum-
ably by increasing the distance between a promoter and
bvgAS. Additionally, we deleted the intergenic region
between fhaB and fimA (which includes the fimA promoter)
in RBX9. The resulting strain RBX9F did not produce LCVs
after modulation. These data strongly support a model in
which a promoter upstream of bvgAS interferes with
normal P2 transcription efficiency, resulting in some cells
having an insufficient quantity of BvgAS to activate tran-
scription at P1.
Each Bvg− phase-trapped bacterium within an LCV
initiates the formation of a new LCV and the proportion
of Bvg− phase-trapped bacteria within an LCV
decreases over time
Our data indicate that LCVs are founded by a single
Bvg− phase-trapped bacterium and that each LCV har-
bours Bvg− phase-trapped bacteria that can propagate
additional LCVs. However, it is unclear whether all Bvg−
phase-trapped bacteria, or only a subset of these cells,
yield LCVs upon replating. To address this question,
we needed two pieces of information: the proportion of
Bvg− phase-trapped bacteria within one LCV and the
frequency of new LCV formation from the same
parent colony when replated. We used RBX9cyaAFLP to
RB50P
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Fig. 5. Sequences upstream of bvgAS affect transcription efficiency under Bvg− phase conditions.
A. Schematics of RB50PshortbvgAFLP and RB50PlongbvgAFLP showing the sequences 5′ to flp inserted at the attTn7 site (not drawn to scale).
B and C. Strains were first grown on BG blood agar + 50 mM MgSO4 + Km and one colony was plated onto BG blood agar + 50 mM MgSO4
(Bvg− phase conditions) without Km selection.
D and E. Strains were grown on BG blood agar + 50 mM MgSO4 + Km selection and then one colony of each was plated onto BG blood agar
(Bvg+ phase conditions) without selection.
Representative white light (left) and fluorescent (right) images are shown for panels B, C, D and E.
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evaluate the composition and LCV-forming capacity of
single LCVs.
Plating a GFP+ LCV onto Bvg− phase conditions, in which
cyaA expression is minimal, will minimize further Flp-
mediated recombination due to cyaA activation during
colony formation, permitting us to determine the proportion
of GFP+ bacteria (and hence Bvg− phase-trapped) that
existed within the original LCV at that time. Plating the
same GFP+ LCV onto Bvg+ phase conditions allows us to
determine the number of new LCVs generated from the
subpopulation of Bvg− phase-trapped bacteria in the parent
LCV. Comparing the frequency of newly generated LCVs
under Bvg+ phase conditions to the frequency of GFP+ cfu
under Bvg− phase conditions will reveal the proportion of
Bvg− phase bacteria that form LCVs when replated.
We first grew RBX9cyaAFLP on Bvg− phase conditions
with Km selection to maintain the gfp and Kmr markers
(Fig. 7A I). Then we took single GFP+ (Bvg− phase) colo-
nies and plated them onto Bvg+ and Bvg− phase conditions
(Fig. 7A II). GFP+ LCVs that were recovered from Bvg+
phase plates were then plated again onto Bvg+ and Bvg−
phase conditions (Fig. 7A III). The frequencies of GFP+ cfu,
LCVs, and Bvg+ phase colonies from each plate were
recorded, and the results from one representative experi-
ment are shown in Fig. 7A. When the GFP+ LCVs were
plated onto Bvg+ and Bvg− phase conditions, there was no
significant difference in the average number of GFP+ cfu
under Bvg− phase conditions compared with the average
number of GFP+ LCVs on the corresponding Bvg+ phase
BG blood agar plate (Fig. 7B). These data suggest that
each Bvg− phase bacterium within an LCV is Bvg− phase-
trapped and forms an LCV when replated onto Bvg+ phase
conditions.
Additionally, we asked if the composition of LCVs (i.e. the
ratio of Bvg− to Bvg+ phase bacteria) changed over time.
We hypothesized that this ratio would change due to
bacterial division as well as the rate of conversion of Bvg−
phase-trapped bacteria to Bvg+ phase bacteria. Because
we expected a unidirectional conversion of phenotypes
(Bvg− to Bvg+ phase only) under Bvg+ phase conditions, we
predicted that the ratio of Bvg− to Bvg+ phase bacteria
would decrease as the bacterial population increased. To
determine if the compositions changed after an additional
day of growth, we compared GFP+ LCVs plated after our
standard incubation time (48 h) (Fig. 7A III) to GFP+ LCVs
plated after 72 h (Fig. 7A IV). When GFP+ LCVs were
plated after 48 h of incubation, we obtained an average of
12 ± 1.2% GFP+ cfu under Bvg− phase conditions, whereas
after 72 h, we obtained an average of 5.75 ± 1% GFP+ cfu
under the same conditions (P = 0.005) (Fig. 7C). These
data indicate that the frequency of GFP+ (and therefore
Bvg− phase-trapped) bacteria in an LCV decreases over
time.
These data also strongly suggest (as discussed in a
previous result) that GFP− LCVs are a result of the back-
ground activation of cyaA in RBX9PcyaAFLP, as the back-
ground cyaA-flp activation under conditions of inactivity
(Bvg− phase conditions) was the same as the frequency of
GFP− LCVs (to total LCVs) under Bvg+ phase conditions
(Fig. 7A II).
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Fig. 6. The genetic architecture of the bvgAS-fhaB intergenic region of strains that do and do not produce LCVs. Strains that produce LCVs
or demonstrate a defect in bvgAS-flp activation have divergent promoters 5′ to the bvgAS-fhaB intergenic region. Schematics for
RB50PshortbvgAFLP and RB50PlongbvgAFLP represent sequences inserted at the attTn7 site. Dotted lines represent non-coding plasmid DNA.
Sequence lengths from the ATG of fhaB to the nearest 5′ ATG are indicated.
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Modulation of RBX9 in vivo occurs at a very
low frequency
All data published thus far strongly suggest that wild-type
Bordetella do not modulate to the Bvgi or Bvg− phase in
vivo and that the Bvg+ phase is necessary and sufficient
for infection (Cotter and Miller, 1994; Akerley et al., 1995;
Merkel et al., 1998; Tejada et al., 1998; Vergara-Irigaray
et al., 2005; Nicholson et al., 2012). The recovery of
LCVs from mouse lung homogenates and the fact that
LCVs were recovered in vitro only following modulation,
however, supports the hypothesis that RBX9 modulates
during infection. To test this hypothesis, we constructed
strain RBX9flaAFLP, a strain containing the pGFLIP cas-
sette in which the flaA promoter drives expression of
flp (Byrd et al., 2013). Previously, using the same PflaA-flp-
containing cassette in wild-type RB50, we showed that
flaA was not activated to a detectable level in RB50 during
murine infection (Byrd et al., 2013). RB50flaAFLP and
RBX9flaAFLP bacteria were grown under Bvg+ phase
conditions with Km selection to minimize background
resolution prior to inoculation. Mice were inoculated
intranasally with 7.5 × 104–1 × 105 cfu and lungs were
harvested at 3, 24, 30 and 72 h post-inoculation. We
conducted this experiment several times. In all experi-
ments, a low proportion (≤ 1%) of GFP− bacteria was
recovered from the lungs of both RB50flaAFLP- and
RBX9flaAFLP-inoculated animals (data not shown). This
low proportion was not significantly different, however,
from the proportion of GFP− bacteria present in the
GFP+ LCV generated in vitro
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Fig. 7. A. Schematic of RBX9cyaAFLP
experimental design, including a data set from
one replicate. Each pie chart represents the
population obtained from plating a single
GFP+ colony from the previous plate (see text
for details). Blue sectors in pie charts
represent the frequency of GFP− cfu; Green
sectors in pie charts represent the frequency
of GFP+ cfu; offset regions of pie charts
represent the frequency of LCVs; Frequencies
were determined by counting at least 500 cfu
per condition.
B. Comparison of GFP+ cfu frequencies
obtained from plating a single GFP+ LCV onto
Bvg+ and Bvg− phase conditions.
C. Comparison of GFP+ cfu frequencies
obtained from plating a GFP+ LCV grown after
48 h and 72 h. Background colour represents
BvgAS conditions, where red is Bvg+ phase
conditions and blue is Bvg− phase conditions.
**P = 0.005 by Student’s unpaired t-test.
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samples used for inoculation (plated after inoculating
the animals). Data from previous work with RB50flaAFLP
(Byrd et al., 2013) and our experiments with
RBX9flaAFLP indicate that resolution of the PflaA-flp cas-
sette is BvgAS-dependent, and GFP− bacteria were not
recovered from strains containing the bvgS-C3 mutation,
which locks the bacteria in the Bvg+ phase (data not
shown). For the RBX9flaAFLP-inoculated animals, most
of the GFP− colonies recovered from the mouse lungs
were LCVs and no GFP+ LCVs were recovered, indicating
that formation of LCVs in vivo correlates with, and is most
likely caused by, BvgAS modulation. Together, these data
suggest that a very small proportion of RBX9 modulates
to the Bvg− phase during infection. However, our data
neither support nor refute the possibility that a small
number of RB50 bacteria modulates as well.
To determine if bacteria modulate to the Bvgi phase
during infection, we attempted to construct strains with
Bvgi phase promoters, including the bipA promoter,
driving flp. However, we were unable to construct these
strains, presumably because the level of expression of
these genes in Bvg+ phase conditions was above the
threshold of flp activation required for recombination and
loss of GFP and KmR.
If BvgAS modulation occurs in vivo, it does not alter the
outcome of infection
Our data suggest that a small proportion RBX9 (and pos-
sibly RB50) bacteria may modulate to the Bvg− phase
during infection. Although several previous experiments
have shown that wild-type and Bvg+ phase-locked
B. bronchiseptica strains are indistinguishable in animal
models (Cotter and Miller, 1994; Merkel et al., 1998;
Tejada et al., 1998; Vergara-Irigaray et al., 2005;
Nicholson et al., 2012), we considered the possibility that
the proportion of RBX9 bacteria that modulate in vivo
could actually be greater than that of RB50, but not
apparent from the PflaA-flp data because modulated RBX9
bacteria are killed in the host (i.e. that modulated bacte-
ria, and perhaps specifically modulated RBX9 bacteria,
are more susceptible to host-mediated clearance than
modulated RB50 bacteria). To test this hypothesis, we
compared RBX9, RBX9c (the Bvg+ phase-locked deriva-
tive of RBX9), RBX9F (the ΔPfimA derivative of RBX9
which is not defective for bvgAS autoregulation), and
RBX9cF (a Bvg+ phase-locked derivative of RBX9F) in
mice. The results of three independent experiments are
shown in Fig. 8. In no case did a statistically significant
difference in bacterial burden occur among the various
strains. These data negate our hypothesis and provide
strong evidence that the low level of BvgAS modulation
that occurs in vivo (based on the recovery of LCVs) does
not impact the outcome of infection.
Discussion
The discovery and characterization of LCVs in B. bron-
chiseptica yielded several interesting findings, the most
significant being evidence that transcriptional interference
can result from activity at a promoter located several
hundred nucleotides 5′ to the affected promoter. Given this
relatively large distance between promoters, the mecha-
nism of interference likely does not involve direct blocking
of transcription; therefore, we suggest the name ‘passive
transcriptional interference’ for this phenomenon. Our data
indicate that the bvgAS P2 promoter is sensitive to passive
transcriptional interference and that it results in the emer-
gence of a bistable phenotype, apparent as LCVs, when
bacteria are switched from Bvg− phase conditions to Bvg+
phase conditions. The fact that LCVs, which contain Bvg−
phase-trapped bacteria, were recovered from the lungs of
infected mice, provided evidence that BvgAS modulation
occurs in vivo. Our experiments indicate, however, that
although a small proportion of bacteria apparently do
modulate during infection, this level of modulation does not
alter the outcome of infection.
Bacterial populations often exhibit phenotypic heteroge-
neity. A common mechanism by which bacteria can gener-
ate this heterogeneity is phase variation, a reversible and
heritable change in phenotype (due to either genetic or
epigenetic modifications) often manifested as different
colony morphologies (Hallet, 2001; van der Woude and
Bäumler, 2004). Phase variation frequently alters the pro-
duction of surface-exposed epitopes such as pili, capsule,
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Fig. 8. Comparison of RBX9, RBX9c, RBX9F, and RBX9cF
burdens in the mouse lung after 3 h and 72 h p.i. RBX9c and
RBX9cF are Bvg+ phase-locked derivatives of RBX9 and RBX9F,
respectively; 4–8-week-old BALB/C mice were intranasally infected
with 1 × 105 cfu in 50 μl and lungs were harvested at each time
point; each diamond or circle indicates the number of cfu recovered
from a single animal and each horizontal line indicates the
geometric mean for each group; these data represent three
independent experiments with at least two mice per strain per time
point.
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flagella, lipopolysaccharide (LPS), and adhesins (van der
Woude and Bäumler, 2004). Coincidently, phase variation
is often associated with virulence and is an important
strategy used by pathogens to avoid immune selection.
Some well-characterized examples of phase variation
include the opa operon encoding adhesin proteins in Neis-
seria species, the pap operon encoding fimbrae in Escheri-
chia coli, and the flagella subunits encoded by fljBA and fliC
in Salmonella enterica serotype Typhimurium (Simon
et al., 1980; Stern and Meyer, 1987; Hernday et al., 2002).
In Bordetella, phase variation in both fim3 and bvgAS has
been described (Stibitz et al., 1989; Willems et al., 1990).
More recently, a phenomenon that generates bistable
populations at the single-cell level has been discovered,
called feedback-based multistability (FBM) (Smits et al.,
2006). FBM is distinct from phase variation in that it is not
based on genetic mutations but is instead based on feed-
back loops of regulatory networks (Smits et al., 2006). In
isogenic populations, these feedback networks can result
in bistability, which occurs when individuals in a popula-
tion exhibit either one of two alternative stable steady-
states (but not intermediate states) (Ferrell, 2002). A
well-characterized example of FBM is in Bacillius subtilis,
in the regulation of competence orchestrated by the tran-
scription factor ComK (van Sinderen et al., 1995). Com-
petence is a cellular state induced by nutrient depletion,
but only occurs in a fraction of the B. subtilis population
due to oscillating levels of ComK at the single-cell level
(Veening et al., 2008; Espinar et al., 2013). In one study,
Smits et al. removed the external regulation of comK,
leaving only positive autoregulation, and showed that
ComK levels continued to exhibit bistability. Therefore, the
authors argue that ComK bistability can be reduced to a
positive autoregulatory loop in concert with random tran-
scriptional and translational fluctuations or ‘noise’ (Smits
et al., 2005). This claim is supported by other examples, in
which feedback regulation and a non-linear input are the
only required components for a bistable system (Ferrell,
2002; Maamar and Dubnau, 2005).
We discovered LCVs of B. bronchiseptica after plating
lung homogenates of mice infected with strain RBX9 and
found that they yielded a heterogeneous population upon
restreaking onto BG blood agar. We did not find evidence
of classical phase variation in RBX9. Instead, the mecha-
nism by which LCVs are generated appears more similar
to FBM, in which the concentration of BvgA under Bvg−
phase conditions varies in the population and results in
some, but not all, bacteria committing to a positive feed-
back loop when switched to Bvg+ phase conditions. In
support of this hypothesis, we were able to label bacteria
within LCVs with tags unique to the Bvg+ and Bvg− phases
and demonstrate the existence of two phenotypically dis-
tinct populations within LCVs (Fig. 3). The dual-tagged
RBX9 strain also provided the first direct evidence that
Bvgi phase cultures are not simply a mixture of Bvg+ and
Bvg− phase bacteria.
Use of the recombinase-based reporter system pGFLIP
(Byrd et al., 2013) showed that the ΔfhaB mutation in RBX9
causes a decrease in the efficiency of bvgAS positive
autoregulation and results in Bvg− phase-trapped bacteria
that decline in proportion over time and can initiate the
formation of new LCVs (Figs 4, 5 and 7). Based on these
results and previous data, we postulate a model of LCV
formation and propagation (Fig. 9). According to this
model, the concentration of BvgA varies in a population
and also in individual cells as they grow and divide. In
RB50, the average concentration of BvgA under Bvg−
phase conditions is such that 100% of the bacteria are able
to respond to Bvg+ phase conditions and transition to the
Bvg+ phase phenotype (Fig. 9A and B). In RBX9, however,
the average concentration of BvgA is decreased under
Bvg− phase conditions compared with wild-type bacteria
(curve shifted to the left in Fig. 9A), such that a subpopu-
lation is below the threshold level required to respond to
Bvg+ phase conditions (Fig. 9B). These bacteria are thus
Bvg− phase trapped and remain phenotypically Bvg− phase
even under Bvg+ phase conditions. Under Bvg+ phase
conditions, these bacteria form LCVs, which continue to
harbour Bvg− phase-trapped bacteria. The Bvg− phase-
trapped bacteria within LCVs occasionally escape to
become Bvg+ phase descendants, possibly through
unequal distribution of BvgA upon cell division or by sto-
chastic accumulation of BvgA (Fig. 9C). Therefore, in this
system, a mutation that decreases the basal concentration
of the positively autoregulated factor (BvgA) results in an
FBM-like phenotype, whereas in other systems, FBM is the
natural mechanism by which bacteria reach a bistable
state.
Our pGFLIP data indicated that the bvgAS positive
autoregulation defect is due to decreased activity of P2.
This result explains why RBX9 has lower levels of BvgA: it
has decreased transcription of bvgAS. Our data suggest
that the reason for decreased transcription is the presence
of a promoter located 5′ to the P2 promoter. This upstream
divergent promoter exerts its negative effects on bvgAS
from relatively far away (∼ 800 bp) and this phenomenon
appears to represent a previously undescribed form of
transcriptional interference (the suppressive influence of
one transcriptional process on another) (Shearwin et al.,
2005). It is unclear whether this promoter must be highly
active or divergently transcribed. However, as with other
examples of transcription interference, we predict that
increasing this promoter’s strength would also increase the
degree of interference (Sneppen et al., 2005). Additionally,
we predict that the orientation of the promoter may not be
important and that reversing its orientation would not
abolish interference if transcription read through was pre-
vented. We do not understand mechanistically how this
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‘passive’ transcriptional interference occurs. One possibil-
ity is that the divergent promoter sequesters RNA poly-
merase away from the sensitive promoter (P2) or that
transcription at this site influences DNA topology in a way
that is prohibitive to P2 activation. These data suggest that
the level of expression from the bvgAS P2 promoter is
poised at the threshold of that required for all cells in the
population to respond to Bvg+ phase conditions when they
are encountered. Although the LCV phenotype appeared
as an artefact of genetic manipulation, our results are
important as they demonstrate a form of transcriptional
interference that, to our knowledge, has not been
described previously, and also because they reveal a
mechanism by which in-frame deletion mutations can have
unanticipated polar effects on neighbouring genes. Fur-
thermore, RBX9 and its derivatives constitute a genetically
tractable system for studying additional mechanisms of
transcriptional interference and details of FBM.
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Fig. 9. Proposed distribution of BvgA concentration within populations of RBX9 and RB50.
A. In the Bvg− phase, a proportion of RBX9 cells (shaded region) are Bvg− phase-trapped [i.e. have a concentration of BvgA below the
threshold (dotted line) necessary to stimulate positive autoregulation upon transition to Bvg+ phase conditions]. By contrast, all RB50 cells
have a level of BvgA sufficient to initiate positive autoregulation upon transition to Bvg+ phase conditions.
B. In the Bvg+ phase, the RBX9 cells that were below the threshold BvgA concentration in the Bvg− phase (shaded region as in A) maintain
their low concentration of BvgA and are thus unable to switch to the Bvg+ phase. These cells are able to initiate LCV formation as described in
C. Consistent with our in vitro data, all RB50 cells are able to switch to the Bvg+ phase.
C. Model of LCV formation and propagation illustrated as a lineage diagram (see text for details). RBX9 bacteria exist as a heterogeneous
population under Bvg− phase conditions, with some bacteria (white) being below the threshold of BvgA required to initiate positive
autoregulation and others above this threshold (grey). When bacteria are switched to the Bvg+ phase, the Bvg− phase trapped bacteria form
LCVs, whereas the other bacteria transition into the Bvg+ phase (black) and form Bvg+ phase colonies. Occasionally, Bvg− phase-trapped
bacteria ‘escape’ and can transition into the Bvg+ phase (indicated by grey cells between white and black cells), resulting in LCV formation
after 48 h.
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The LCVs also provided insight into the behaviour of
BvgAS during infection. The role of BvgAS-dependent
modulation in the Bordetella life cycle is not completely
understood and remains an important area of investiga-
tion. Several studies have attempted to determine if Bvgi
or Bvg− phase bacteria exist at any point during Bordetella
infection, and so far none have yielded positive results
(Cotter and Miller, 1994; Merkel et al., 1998; Tejada et al.,
1998; Vergara-Irigaray et al., 2005; Nicholson et al.,
2012). These data, together with those demonstrating that
Bvg− phase bacteria transition rapidly to the Bvg+ phase
following intranasal inoculation (Veal-Carr and Stibitz,
2005; Byrd et al., 2013), have led to the conclusion that
not only is the Bvg+ phase necessary and sufficient for
infection, but that bacteria switch to and remain in the
Bvg+ phase in vivo. The Bvgi and Bvg− phases are hypoth-
esized to be important for transmission and survival ex
vivo, however, no role for these phenotypic phases in a
natural setting has been demonstrated. For B. pertussis
particularly, which appears to survive outside the host only
briefly during transmission to a new host, the role of
BvgAS modulation remains mysterious. The isolation of
LCVs from mouse lungs provides strong evidence that at
least some RBX9 bacteria modulate during infection.
However, the proportion of bacteria that modulated and
that could be recovered from the animals was very low.
Because the PflaA-flp system was unable to reliably distin-
guish this low proportion of modulated bacteria from back-
ground resolution, we could not determine if wild type
bacteria modulate in vivo. If they do not, our data would
suggest that only FHA-deficient bacteria modulate in vivo,
which would suggest that FHA functions to prevent the
bacteria from experiencing a Bvg− phase environment
during infection. In pilot experiments, we also recovered
LCVs from mice infected with ΔfhaB, ΔcyaA double
mutants – in higher proportions, in some cases, than in
mice infected with RBX9. These preliminary data suggest
the intriguing possibility that FHA and ACT function
together to prevent Bordetella from creating or entering a
modulating environment in the host. Our future experi-
ments will be aimed at testing this hypothesis.
Experimental procedures
Strains and growth conditions
Escherichia coli were grown in lysogeny broth (LB; 10 g l−1
tryptone, 5 g l−1 yeast extract, 2.5 g l−1 NaCl) or on LB with
agar (1.5%) at 37°C. Bordetella were grown in SS broth or on
BG agar (1.5%) (BD Biosciences, San Jose, CA) supple-
mented with 7.5% defibrinated sheep’s blood (Colorado
Serum Company, Denver, CO) at 37°C. As required, culture
media were supplemented with kanamycin (Km; 50 μg ml−1),
ampicillin (Ap; 100 μg ml−1), streptomycin (Sm; 25 μg ml−1),
magnesium sulphate (MgSO4; 50 mM in plates and 20 mM in
liquid), and diaminopimelic acid (DAP; 400 μg ml−1) for the
E. coli mobilizer strain RHO3 (Δasd ΔaphA). Unless other-
wise noted, all restriction enzymes and T4 DNA ligase was
purchased from New England Biolabs. For a complete list of
the strains and plasmids used in this study, see Table S1.
Construction of bacterial strains
Allelic exchange and Campbell-type integrations were done
by matings using parental Bordetella and E. coli strain
RHO3 harbouring the appropriate suicide plasmid. The
pGFLIP plasmid was delivered to the attTn7 site using tri-
parental mating with the above strains and with RHO3 cells
harbouring pTNS3, which encodes the transposase genes
tnsABCD. Integration at the attTn7 locus was confirmed via
PCR. For details on specific strain constructions see the
Supplemental text.
Immunofluorescence
HA epitopes on the surface of RBX9BatB-HAflaA-gfp bacteria
were stained and visualized using indirect immunofluores-
cence. After 72 h of growth at 37°C, five to 20 colonies of
each morphology including Bvg+, Bvg−, Bvgi, and LCV, were
scraped off of BG blood agar plates and resuspended into
1 ml of 4% paraformaldehyde and were allowed to fix on ice
for 30 min. Cells were pelleted and washed with 1% BSA in
PBS in a microcentrifuge tube. Primary antibody (mouse
monoclonal anti-HA IgG diluted 1:2000 in 1% BSA in PBS)
was used to resuspend the pellet and this mixture was incu-
bated for 1 h at room temperature (RT). The pellets were
washed twice in 1% BSA for 5 min. Secondary antibody
(Alexa Fluor 594-conjugated goat anti-mouse IgG, diluted
1:250 in 1% BSA in PBS; Invitrogen) was used to resuspend
the pellet and this mixture was then incubated for 30 min at
RT in the dark. The pellets were washed twice with 1% BSA
for 5 min. Four microlitres of the leftover pellet and liquid was
pipetted onto a slide for visualization.
Confocal microscopy
Immunofluorescent RBX9BatB-HAflaA-gfp bacteria were
visualized using a Zeiss LSM 710 confocal microscope. Sec-
ondary antibody (Alexa Fluor 594-conjugated goat anti-
mouse IgG) was detected using a 594 nm laser and GFP was
detected at 488 nm. We used the 63× oil objective with 3×
digital zoom. Images were viewed and saved with the Zen
software from Carl Zeiss Microscopy.
pGFLIP assays
For RBX9cyaAFLP, RB50PbvgAshortFLP and
RB50PbvgAlongFLP, strains were grown on BG blood agar
plates under promoter-inactive conditions (Bvg− phase) with
Km for 48 h at 37°C and were determined to be GFP positive
(GFP+) using a G:BOX Chemi imaging system with an
UltraBright-LED blue transilluminator and an SW06 short-
pass filter (495 to 600 nm; Syngene, Frederick, MD). Single
GFP+ colonies were then resuspended in PBS, diluted, and
plated onto Bvg+ or Bvg− phase conditions (promoter-active
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and promoter-inactive conditions respectively) in the absence
of Km selection. For RBX9cyaAFLP, GFP+ LCVs were picked,
diluted, and plated onto Bvg+ and Bvg− phase conditions in the
absence of Km selection. Percent resolution was determined
by averaging the ratio of GFP− cfu/total cfu for at least three
plates.
Intranasal inoculation of mice
Four- to 8-week-old BALB/c mice (Jackson Laboratories, Bar
Harbor, ME) were inoculated intranasally with 1 × 105 cfu of
B. bronchiseptica in 50 μl of PBS. For all infections, bacteria
were grown overnight in SS medium. Lungs were harvested at
1 h and 72 h p.i. Right lungs were homogenized in 1 ml of
PBS, diluted in PBS, and plated in at least duplicate on BG
agar. Figure 8 represents data from three independent experi-
ments performed with at least two mice per strain per time
point.
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Labo-
ratory Animals of the National Institutes of Health. Our proto-
col was approved by the University of North Carolina IACUC
(10-134, 12-307). All animals were properly anesthetized for
inoculations, monitored regularly, euthanized when mori-
bund, and efforts were made to minimize suffering.
Statistical analyses
Statistical analyses were performed using Prism 5.0
(GraphPad Software). Statistical significance was deter-
mined using the unpaired Student’s t-test or analysis of vari-
ance (ANOVA) followed by Tukey’s multiple comparison test.
Images were formatted using Adobe Photoshop CS5 and
figures were generated using Adobe Illustrator CS5 (Adobe
Systems).
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